A Double-Blind, Randomized, Placebo-Controlled Trial of Soluble Epoxide Hydrolase Inhibition in Patients with Aneurysmal Subarachnoid Hemorrhage

Underlying Mechanisms and Potential Therapeutic Molecular Targets in Blood-Brain Barrier Disruption After Subarachnoid Hemorrhage

(2020) Yuchen Li et al.   Current Neuropharmacology

Neuroinflammation and Microvascular Dysfunction After Experimental Subarachnoid Hemorrhage: Emerging Components of Early Brain Injury Related to Outcome

(2019) Joseph R. Geraghty et al.   Neurocritical Care

Humble beginnings with big goals: Small molecule soluble epoxide hydrolase inhibitors for treating CNS disorders

(2018) Sydney Zarriello et al.   PROGRESS IN NEUROBIOLOGY

Cytochrome P450 eicosanoids in cerebrovascular function and disease

(2017) Catherine M. Davis et al.   PHARMACOLOGY & THERAPEUTICS

Functional screening for G protein-coupled receptor targets of 14,15-epoxyeicosatrienoic acid

(2017) Xuehong Liu et al.   PROSTAGLANDINS & OTHER LIPID MEDIATORS

Interleukin 6 in the Cerebrospinal Fluid as a Biomarker for Onset of Vasospasm and Ventriculitis After Severe Subarachnoid Hemorrhage

(2017) Markus Lenski et al.   World Neurosurgery

Cerebrospinal Fluid and Microdialysis Cytokines in Aneurysmal Subarachnoid Hemorrhage: A Scoping Systematic Review

(2017) Frederick A. Zeiler et al.   Frontiers in Neurology

Delayed cerebral ischaemia prevention and treatment after aneurysmal subarachnoid haemorrhage: a systematic review

(2016) M. Veldeman et al.   BRITISH JOURNAL OF ANAESTHESIA

Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitor

(2016) Aili L. Lazaar et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Soluble Epoxide Hydrolase in Hydrocephalus, Cerebral Edema, and Vascular Inflammation After Subarachnoid Hemorrhage

(2015) Dominic A. Siler et al.   STROKE

Soluble Epoxide Hydrolase as an Anti-inflammatory Target of the Thrombolytic Stroke Drug SMTP-7

(2014) Naoki Matsumoto et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Genetic Markers in the EET Metabolic Pathway Are Associated with Outcomes in Patients with Aneurysmal Subarachnoid Hemorrhage

(2014) Mark K Donnelly et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Genetic variation in soluble epoxide hydrolase: association with outcome after aneurysmal subarachnoid hemorrhage

(2014) Ross P. Martini et al.   JOURNAL OF NEUROSURGERY

Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data From 6 Countries

(2011) H. Quan et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Definition of Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage as an Outcome Event in Clinical Trials and Observational Studies

(2010) Mervyn D.I. Vergouwen et al.   STROKE

Epoxyeicosanoid signaling in CNS function and disease

(2009) Jeffrey J. Iliff et al.   PROSTAGLANDINS & OTHER LIPID MEDIATORS

A rank‐based sample size method for multiple outcomes in clinical trials

(2008) Peng Huang et al.   STATISTICS IN MEDICINE

Soluble Epoxide Hydrolase Gene Deletion Is Protective Against Experimental Cerebral Ischemia

(2008) Wenri Zhang et al.   STROKE